Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/76963
Campo DC Valoridioma
dc.contributor.authorCulebras, C.en_US
dc.contributor.authorIrurita, Maria M.en_US
dc.contributor.authorIrurita, J.en_US
dc.contributor.authorFuentes, J.en_US
dc.contributor.authorLópez, L.en_US
dc.contributor.authorDeniz, C.en_US
dc.contributor.authorMartínez Saavedra, M.en_US
dc.contributor.authorChirino Godoy, Ricardoen_US
dc.contributor.authorNieto, V.en_US
dc.date.accessioned2020-12-23T13:15:49Z-
dc.date.available2020-12-23T13:15:49Z-
dc.date.issued2004en_US
dc.identifier.issn1567-5688en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/76963-
dc.description.abstractPatients with prematme coronary syndromes impose an enormous challenge to the long-term management of atherosclerosis. Though the inflammatory markers available are sensible, but lack specificity and are not permanent. We analysed the polymorphisms of two pleiotropic inflammatory media- tors, interleukin IL-8 (-251 A/T), and IL-6 (-174 G/C) promoters. PCR-SSP techniques rendered hyper, medium and hypoproductive phenotypes. We studied 393 patients (P), after a premature coronary syndrome were com- pared with 276 aged, healthy controls (C); both had similar AA-AT/TT and GG-GC/CC distributions. Results: Patients were 44 years old and controls 69; (p<0.000). With the exception of smoking (P81% vs. c52%; p<0.000), dyslipidemia (P63% vs. c37%; p<0.05), and family history of premature CHD (P37%vs. c14%; p<0.000) major risk factors were more prevalent among conU'ols. Patient study showed males were 4 years younger (F47 vs. M43; p<0.048). Gen- der diffelences included higher prevalence of diabetics (M74%vs. F25%; p<0.028), and smokers (M86%vs. F14%; p<0.000) among males. Multi- vessel disease related to dyslipidemia (86%; p<0.007), metabolic syndrome (35%; p<0.041) and hyperproductive IL-8 phenotype (75%; p<0.033) in males. Reculxence related to smoking (p<0.045), diabetes (p<0.05) and PCI (p<0.041). Hyperproductive IL-6 col~elated with metabolic syndrome (p<0.001) and IL-8 with multivessel disease (p<0.011). Hyperproductive IL-8 phenotype (p<0.010) explained 73.4% of recua~ence in a logistic regression model built with risk factors, gender, clinical features and both phenotypes. Conclusions: Despite an unusual model with a considerable age gap between patients and controls, patients had a higher prevalence of some major risk factors. Hyperproductive interleukin-8 phenotype is a suitable and permanent marker of rectuxence that may conU'ibute to characterise individual variability.en_US
dc.languageengen_US
dc.relation.ispartofAtherosclerosis Supplementsen_US
dc.sourceAtherosclerosis Supplements [ISSN 1567-5688], v. 5 (1) sup. S, p. 4, 2004en_US
dc.subject32 Ciencias médicasen_US
dc.subject.otherAtherosclerosisen_US
dc.subject.otherCoronary arteriosclerosisen_US
dc.subject.otherPhenotypeen_US
dc.titleW01.15. Interleukin inflammatory phenotypes in premature coronary atherosclerosisen_US
dc.typeinfo:eu-repo/semantics/conferenceObjecten_US
dc.typeConferenceObjecten_US
dc.relation.conference74th Congress of the European-Atherosclerosis-Societyen_US
dc.identifier.doi10.1016/S1567-5688(04)90015-9en_US
dc.identifier.isi000221639000016-
dc.description.lastpage4en_US
dc.identifier.issue1-
dc.description.firstpage4en_US
dc.relation.volume5en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Actas de congresosen_US
dc.contributor.daisngid1456553-
dc.contributor.daisngid1534651-
dc.contributor.daisngid1533088-
dc.contributor.daisngid1942381-
dc.contributor.daisngid28238373-
dc.contributor.daisngid10570973-
dc.contributor.daisngid6278241-
dc.contributor.daisngid880609-
dc.contributor.daisngid25611320-
dc.description.numberofpages1en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Culebras, C-
dc.contributor.wosstandardWOS:Irurita, M-
dc.contributor.wosstandardWOS:Irurita, J-
dc.contributor.wosstandardWOS:Fuentes, J-
dc.contributor.wosstandardWOS:Lopez, L-
dc.contributor.wosstandardWOS:Deniz, C-
dc.contributor.wosstandardWOS:Saavedra, MM-
dc.contributor.wosstandardWOS:Chirino, R-
dc.contributor.wosstandardWOS:Nieto, V-
dc.date.coverdateAbril 2004en_US
dc.identifier.supplementS-
dc.identifier.conferenceidevents120406-
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr4,14
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.event.eventsstartdate17-04-2004-
crisitem.event.eventsenddate17-04-2004-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0002-5681-8931-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameChirino Godoy, Ricardo-
Colección:Actas de congresos
Adobe PDF (141,38 kB)
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.